CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST

  2024-11-27 |   Pages: 200+ |   Report ID: MD-R-2024-11-27-177336 |   Others

Historical data: 2018 - 2023

Forecast period: 2024 - 2031

Quantitative units: Revenue in USD million and CAGR from 2024 to 2031

Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends

Cell and advanced therapy supply chain management Market

Image

1.1 SCOPE OF THE REPORT

1.2 MARKET SEGMENT ANALYSIS

1.3 REGULATORY SCENARIO BY REGION/COUNTRY

1.4 MARKET INVESTMENT SCENARIO STRATEGIC

1.5 MARKET ANALYSIS BY TYPE (USD MILLION)

1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)

2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS

  2.1.1 MARKET DRIVER ANALYSIS

  2.1.2 MARKET RESTRAINT ANALYSIS

  2.1.3 MARKET OPPORTUNITY

  2.1.4 MARKET CHALLENGES

3.1 INDUSTRY TRENDS

  3.1.1 SWOT ANALYSIS

  3.1.2 PESTEL ANALYSIS

  3.1.3 PORTER’S FIVE FORCES ANALYSIS

3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS

4.1 COVID-19 ANALYSIS

5.1 GLOBAL CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET, SALES AREA, TYPE

5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET

7.1 GLOBAL CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE (2018-2031) (USD MILLION)

8.1 GLOBAL CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

8.2 GLOBAL CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

9.1 GLOBAL CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

9.2 GLOBAL CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

10.1 GLOBAL CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)

10.2 GLOBAL CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)

11.1 NORTH AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

11.2 NORTH AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

11.3 NORTH AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

11.4 NORTH AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

11.5 NORTH AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

11.6 NORTH AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

12.1 EUROPE CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

12.2 EUROPE CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

12.3 EUROPE CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

12.4 EUROPE CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

12.5 EUROPE CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

12.6 EUROPE CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

13.1 ASIA PACIFIC CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

13.2 ASIA PACIFIC CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

13.3 ASIA PACIFIC CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

13.4 ASIA PACIFIC CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

13.5 ASIA PACIFIC CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

13.6 ASIA PACIFIC CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

14.1 LATIN AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>

14.2 LATIN AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

14.3 LATIN AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

14.4 LATIN AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

14.5 LATIN AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

14.6 LATIN AMERICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)

15.1 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)

15.2 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)

15.3 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)

15.4 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)

15.5 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)

15.6 MIDDLE EAST & AFRICA CELL AND ADVANCED THERAPY SUPPLY CHAIN MANAGEMENT MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>

16.1 sedApta Group

  16.1.1 COMPANY DETAILS

  16.1.2 FINANCIALS (USD MILLION)

  16.1.3 PRODUCT SUMMARY

  16.1.4 RECENT DEVELOPMENTS

16.2 TrakCel

16.3 MasterControl

16.4 Stafa Cellular Therapy

16.5 Hypertrust Patient Data Care

16.6 Haemonetics

16.7 MAK-SYSTEM

16.8 Lykan Bioscience

16.9 SAP

16.10 Title21 Health Solutions

16.11 Cryoport

16.12 Be The Match BioTherapies

16.13 Clarkston Consulting

16.14 Brooks Life Sciences

16.15 Vineti

16.16 SAVSU Technologies

16.17 TraceLink

18.1 METHODOLOGY

18.2 RESEARCH DATA SOURCE

  18.2.1 SECONDARY DATA

  18.2.2 KEY DATA FROM SECONDARY

  18.2.3 PRIMARY DATA

  18.2.4 KEY DATA FROM PRIMARY

  18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS

  18.2.6 MARKET ESTIMATION

  18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH

  18.2.8 LEGAL DISCLAIMER

Market Segments

Major Types Covered
local
cloud

Major Downstream Industry Covered
Research institutions
hospital
Cell Therapy Lab
Biobank
Business organization

Companies

sedApta Group
TrakCel
MasterControl
Stafa Cellular Therapy
Hypertrust Patient Data Care
Haemonetics
MAK-SYSTEM
Lykan Bioscience
SAP
Title21 Health Solutions
Cryoport
Be The Match BioTherapies
Clarkston Consulting
Brooks Life Sciences
Vineti
SAVSU Technologies
TraceLink

Single User License  : 3900$
Corporate License    : 7800$
Enquiry Before Buying
Request For Customization
Speak To Analyst

BROWSE INDUSTRY

  1. Consumer Goods
  2. Healthcare
  3. Food & Beverage
  4. Heavy Industry
  5. Service Industries
  6. FMCG
  7. Life Sciences
  8. Technology & Media
  9. Machinery & Equipment

    WHY CHOOSE US

  •   PROACTIVE

    • We manage our resources 24/7 to identify issues and address them before they become problems.

  •   QUALITY & RELIABILITY

    • We are committed to providing reliable and highly accurate data with an excellent quality control system.

  •   GLOBAL OUTREACH

    • 6 Major regions and 40+ countries level analysis accomplished.

  •   COMPETITIVE PRICING

    • Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.